Xtant Medical Holdings, Inc. (XTNT)
USD 0.36
(-2.07%)
USD 0.36
(-2.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 91.3 Million | 57.96 Million | 55.26 Million | 53.33 Million | 64.68 Million | 72.2 Million |
| Cost of Revenue | 35.83 Million | 25.83 Million | 22.77 Million | 18.94 Million | 22.16 Million | 28.71 Million |
| Gross Profit | 55.46 Million | 32.13 Million | 32.49 Million | 34.39 Million | 42.51 Million | 43.48 Million |
| Operating Expenses | 65.62 Million | 38.89 Million | 36.34 Million | 35.14 Million | 44.76 Million | 50.88 Million |
| Selling, General and Administrative Expenses | 64.28 Million | 37.97 Million | 35.47 Million | 34.48 Million | 43.77 Million | 45.06 Million |
| Research and Development Expenses | 1.33 Million | 915 Thousand | 870 Thousand | 657 Thousand | 932 Thousand | 1.7 Million |
| Other Expenses | - | - | - | - | 58 Thousand | 3000.00 |
| Cost and Expenses | 101.46 Million | 64.72 Million | 59.11 Million | 54.08 Million | 66.93 Million | 79.59 Million |
| Operating Income | -10.15 Million | -6.75 Million | -3.85 Million | -751 Thousand | -2.35 Million | -60.07 Million |
| Interest Expense | 2.93 Million | 1.69 Million | 995 Thousand | 5.97 Million | 5.77 Million | 10.14 Million |
| Income Tax Expense | -1.69 Million | 69 Thousand | 995 Thousand | 296 Thousand | 98 Thousand | 124 Thousand |
| Earnings before Tax | -1.03 Million | -8.41 Million | -4.84 Million | -6.72 Million | -8.12 Million | -70.09 Million |
| Net Income | 660 Thousand | -8.48 Million | -5.84 Million | -7.02 Million | -8.22 Million | -70.09 Million |
| Earnings Per Share Basic | 0.01 | -0.09 | -0.07 | -0.25 | -0.62 | -5.97 |
| Earnings Per Share Diluted | 0.01 | -0.09 | -0.07 | -0.25 | -0.62 | -5.93 |
| Weighted Average Shares Outstanding | 119.09 Million | 94.08 Million | 85.45 Million | 28.49 Million | 13.16 Million | 11.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 126.79 Million | 94.08 Million | 85.45 Million | 28.49 Million | 13.16 Million | 11.82 Million |
| Gross Margin | 0.61 | 0.55 | 0.59 | 0.64 | 0.66 | 0.60 |
| EBIT Margin | -0.08 | -0.09 | -0.05 | 0.02 | 0.01 | -0.01 |
| Profit Margin | 0.01 | -0.15 | -0.11 | -0.13 | -0.13 | -0.97 |
| EBITDA | -6.98 Million | -5.42 Million | -2.51 Million | 1.32 Million | 850 Thousand | -54.21 Million |
| Earnings Before Tax Margin | -0.11 | -0.12 | -0.07 | -0.01 | -0.04 | -0.83 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 29.94 Million | 27.87 Million | 91.3 Million | 28.1 Million | 25.01 Million | 20.23 Million |
| Cost of Revenue | 11.36 Million | 10.57 Million | 35.83 Million | 10.97 Million | 9.68 Million | 7.77 Million |
| Gross Profit | 18.58 Million | 17.3 Million | 55.46 Million | 17.13 Million | 15.33 Million | 12.45 Million |
| Operating Expenses | 21.52 Million | 20.77 Million | 65.62 Million | 20.94 Million | 18.71 Million | 13.85 Million |
| Selling, General and Administrative Expenses | 20.89 Million | 20.24 Million | - | 20.45 Million | 18.22 Million | 13.67 Million |
| Research and Development Expenses | 636 Thousand | 527 Thousand | - | 492 Thousand | 490 Thousand | 180 Thousand |
| Other Expenses | -5000.00 | 12 Thousand | -49 Thousand | - | - | - |
| Cost and Expenses | 32.88 Million | 31.34 Million | 101.46 Million | 31.91 Million | 28.4 Million | 21.62 Million |
| Operating Income | -2.94 Million | -3.47 Million | -10.15 Million | -3.8 Million | -3.38 Million | -1.39 Million |
| Interest Expense | 992 Thousand | 835 Thousand | 2.93 Million | 818 Thousand | -760 Thousand | 786 Thousand |
| Income Tax Expense | 36 Thousand | 68 Thousand | -1.69 Million | 577 Thousand | 2.3 Million | 13 Thousand |
| Earnings before Tax | -3.82 Million | -4.33 Million | -1.03 Million | -3.72 Million | 6.93 Million | -2.17 Million |
| Net Income | -3.86 Million | -4.4 Million | 660 Thousand | -4.3 Million | 9.23 Million | -2.19 Million |
| Earnings Per Share Basic | -0.03 | -0.03 | - | -0.03 | 0.07 | -0.02 |
| Earnings Per Share Diluted | -0.03 | -0.03 | - | -0.03 | 0.07 | -0.02 |
| Weighted Average Shares Outstanding | 130.26 Million | 130.2 Million | 119.09 Million | 130.02 Million | 128.14 Million | 108.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 130.26 Million | 130.2 Million | 126.79 Million | 130.02 Million | 135.66 Million | 108.89 Million |
| Gross Margin | 0.62 | 0.62 | 0.61 | 0.61 | 0.61 | 0.62 |
| EBIT Margin | -0.07 | -0.09 | - | -0.10 | -0.14 | -0.03 |
| Profit Margin | -0.13 | -0.16 | 0.01 | -0.15 | 0.37 | -0.11 |
| EBITDA | -1.94 Million | -2.46 Million | - | -2.78 Million | -3.38 Million | -588 Thousand |
| Earnings Before Tax Margin | -0.10 | -0.12 | -0.11 | -0.14 | -0.14 | -0.07 |
YRBAF
HWDN
4401
NEM
ANDR
600556